PNPLA3 and liver disorder: ,82 This study found that the first group—dominated by PNPLA3 and TM6SF2 variants—is associated with lower serum triglycerides and either protection or no association with cardiovascular disease but markedly increased risk of advanced liver disease, including HCC.